HSHS St. Elizabeth's Hospital

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 83.00 %	83.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 62.00 %	62.00 %
Q4 2020 - Q1 2021 Result 74.00 %	74.00 %
Q4 2019 - Q1 2020 Result N/A %	N/A %
Q4 2018 - Q1 2019 Result 84.00 %	84.00 %
Q4 2017 - Q1 2018 Result 82.00 %	82.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

HSHS St. Elizabeth's Hospital

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 1 infections, 51665 patient days Rating SIR: 0.48	1 infections, 51665 patient days	0.48
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 3 infections, 50784 patient days Rating SIR: 1.36	3 infections, 50784 patient days	1.36
Q1 2021 - Q4 2021 Result 2 infections, 48602 patient days Rating SIR: 0.81	2 infections, 48602 patient days	0.81
Q1 2020 - Q4 2020 Result 3 infections, 48195 patient days Rating SIR: 1.36	3 infections, 48195 patient days	1.36
Q1 2019 - Q4 2019 Result 4 infections, 44128 patient days Rating SIR: 1.72	4 infections, 44128 patient days	1.72
Q1 2018 - Q4 2018 Result 0 infections, 40161 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 40161 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 34088 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 34088 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 0 infections, 33226 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 33226 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 2 infections, 42297 patient days Rating SIR: 0.77	2 infections, 42297 patient days	0.77
Q1 2014 - Q4 2014 Result 3 infections, 53831 patient days Rating SIR: 1.18	3 infections, 53831 patient days	1.18
Q1 2013 - Q4 2013 Result 0 infections, 49489 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 49489 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2012 - Q4 2012 Result 1 infections, 46850 patient days Rating SIR: 0.42	1 infections, 46850 patient days	0.42
Q1 2012 - Q2 2012 Result 1 infections, 25132 patient days Rating SIR: 0.40	1 infections, 25132 patient days	0.40
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 5 infections, 50106 patient days Rating SIR: 0.18	5 infections, 50106 patient days	0.18
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 15 infections, 48934 patient days Rating SIR: 0.53	15 infections, 48934 patient days	0.53
Q1 2021 - Q4 2021 Result 12 infections, 46588 patient days Rating SIR: 0.49	12 infections, 46588 patient days	0.49
Q1 2020 - Q4 2020 Result 6 infections, 46325 patient days Rating SIR: 0.20	6 infections, 46325 patient days	0.20
Q1 2019 - Q4 2019 Result 11 infections, 42077 patient days Rating SIR: 0.38	11 infections, 42077 patient days	0.38
Q1 2018 - Q4 2018 Result 6 infections, 38193 patient days Rating SIR: 0.22	6 infections, 38193 patient days	0.22
Q1 2017 - Q4 2017 Result 15 infections, 32645 patient days Rating SIR: 0.68	15 infections, 32645 patient days	0.68
Q1 2016 - Q4 2016 Result 25 infections, 30984 patient days Rating SIR: 1.01	25 infections, 30984 patient days	1.01
Q1 2015 - Q4 2015 Result 25 infections, 40626 patient days Rating SIR: 0.63	25 infections, 40626 patient days	0.63
Q1 2014 - Q4 2014 Result 38 infections, 51616 patient days Rating SIR: 0.89	38 infections, 51616 patient days	0.89
Q1 2013 - Q4 2013 Result 42 infections, 47704 patient days Rating SIR: 1.18	42 infections, 47704 patient days	1.18
Q1 2012 - Q4 2012 Result 20 infections, 44168 patient days Rating SIR: 0.73	20 infections, 44168 patient days	0.73

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 0 infections, 2567 central-line days Rating SIR: 0.00	0 infections, 2567 central-line days	0.00
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 4 infections, 2747 central-line days Rating SIR: 1.49	4 infections, 2747 central-line days	1.49
Q1 2021 - Q4 2021 Result 2 infections, 3178 central-line days Rating SIR: 0.64	2 infections, 3178 central-line days	0.64
Q1 2020 - Q4 2020 Result 2 infections, 2741 central-line days Rating SIR: 0.75	2 infections, 2741 central-line days	0.75
Q1 2019 - Q4 2019 Result 2 infections, 2970 central-line days Rating SIR: 0.69	2 infections, 2970 central-line days	0.69
Q1 2018 - Q4 2018 Result 0 infections, 2730 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 2730 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 3 infections, 1746 central-line days Rating SIR: 1.75	3 infections, 1746 central-line days	1.75
Q1 2016 - Q4 2016 Result 0 infections, 1668 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1668 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 2 infections, 2034 central-line days Rating SIR: 0.47	2 infections, 2034 central-line days	0.47
Q1 2014 - Q4 2014 Result 4 infections, 2517 central-line days Rating SIR: 1.06	4 infections, 2517 central-line days	1.06
Q1 2013 - Q4 2013 Result 0 infections, 2066 central-line days Rating SIR: 0.00	0 infections, 2066 central-line days	0.00
Q1 2012 - Q4 2012 Result 1 infections, 1777 central-line days Rating SIR: 0.38	1 infections, 1777 central-line days	0.38
Q1 2011 - Q4 2011 Result 4 infections, 1364 central-line days Rating SIR: 1.96	4 infections, 1364 central-line days	1.96
Q1 2010 - Q4 2010 Result 4 infections, 1628 central-line days Rating SIR: 1.64	4 infections, 1628 central-line days	1.64
Q1 2009 - Q4 2009 Result 1 infections, 2095 central-line days Rating SIR: 0.32	1 infections, 2095 central-line days	0.32
Q1 2009 - Q2 2009 Result 1 infections, 1335 central-line days Rating SIR: 0.75	1 infections, 1335 central-line days	0.75

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2011 - Q4 2011 Result 0 infections, 11 central-line days ³³ Rating SIR: N/A ³³	0 infections, 11 central-line days ³³	N/A ³³
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2010 - Q4 2010 Result 0 infections, 27 central-line days ³³ Rating SIR: 0.00 ³³	0 infections, 27 central-line days ³³	0.00 ³³
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result 0 infections, 138 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 138 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 133 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 133 procedures ¹⁵³	N/A ¹⁵³
Q1 2018 - Q4 2018 Result 0 infections, 93 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 93 procedures ¹⁵³	N/A ¹⁵³
Q1 2017 - Q4 2017 Result 1 infections, 108 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 108 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2016 - Q4 2016 Result 0 infections, 89 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 89 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 0 infections, 117 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 117 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 108 procedures Rating SIR: N/A	0 infections, 108 procedures	N/A
Q3 2013 - Q2 2014 Result 1 infections, 138 procedures Rating SIR: 0.86	1 infections, 138 procedures	0.86
Q3 2012 - Q2 2013 Result 0 infections, 89 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 89 procedures ¹¹⁸	N/A ¹¹⁸
Q3 2011 - Q2 2012 Result 0 infections, 97 procedures ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 97 procedures ⁴⁵	N/A ⁴⁵
Q3 2010 - Q2 2011 Result 1 infections, 77 procedures ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 77 procedures ⁴⁷	N/A ⁴⁷
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result 0 infections, 91 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 91 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 2 infections, 140 procedures Rating SIR: 1.78	2 infections, 140 procedures	1.78
Q1 2018 - Q4 2018 Result 0 infections, 155 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 155 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 1 infections, 119 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 119 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2015 - Q4 2015 Result 2 infections, 113 procedures Rating SIR: 1.15	2 infections, 113 procedures	1.15
Q1 2014 - Q4 2014 Result 0 infections, 122 procedures Rating SIR: 0.00	0 infections, 122 procedures	0.00
Q3 2013 - Q2 2014 Result 1 infections, 130 procedures Rating SIR: 0.51	1 infections, 130 procedures	0.51
Q3 2012 - Q2 2013 Result 0 infections, 105 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 105 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 0 infections, 89 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 89 procedures ⁴⁶	0.00 ⁴⁶
Q3 2010 - Q2 2011 Result 1 infections, 106 procedures Rating SIR: 0.64	1 infections, 106 procedures	0.64